论文部分内容阅读
本次文通过对比应用聚乙二醇干扰素α及常规普通干扰素治疗HBeAg慢性乙型肝炎的临床疗效,探讨其应答指导治疗策略及停药时机,为临床应用提供部分参考。现报告如下。1资料与方法1.1临床资料选择2013年6月至2015年3月于我院就诊并确诊为HBeAg阴性的慢性乙型肝炎患者80例。随机分为对照组40例应用常规普通干扰素治疗,其中男28例,女12例,年龄21~56岁,平均(41.6±2.3)岁;研究组40例应用聚
This article by comparing the application of pegylated interferon alpha and conventional interferon treatment of HBeAg chronic hepatitis B clinical efficacy of its response to guide the treatment strategy and the timing of withdrawal, to provide some reference for clinical applications. The report is as follows. 1 Materials and Methods 1.1 Clinical data selected in June 2013 to March 2015 in our hospital and diagnosed as HBeAg-negative patients with chronic hepatitis B in 80 cases. Randomly divided into control group of 40 patients treated with conventional interferon, including 28 males and 12 females, aged 21 to 56 years old, with an average (41.6 ± 2.3) years; the study group of 40 patients with poly